For example, the blockade of PAX5 (also known as B cell-specific activator protein) (63) and changes in X-box-binding protein (62) TF splicing induce differentiation and targeting these proteins has been shown to reduce bortezomib resistance in MM (64). The gene discussed is PAX5; the disease is Miyoshi myopathy.